News + Filings Transactions
|
BUCHEN DAVID A
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/03/2020 | Amneal Pharmaceuticals, Inc. | AMRX | Exercise | Restricted Stock Units | 27.6k | $0.00 | $0 | | 01/03/2020 |
| 01/03/2020 | Amneal Pharmaceuticals, Inc. | AMRX | Payment of Exercise | Class A Common Stock | 8.2k | $4.72 | $38.6k | | 01/03/2020 |
| 01/03/2019 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Stock Option | 227.3k | $13.58 | $3.1M | | 01/03/2019 |
| 01/03/2019 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Restricted Stock Units | 110.5k | $0.00 | $0 | | 01/03/2019 |
| 03/05/2015 | Allergan plc | AGN | Payment of Exercise | Ordinary Shares, par value $0.0001 | 448 | $295.70 | $132.5k | | 03/05/2015 |
| 03/05/2015 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 4k | $0.00 | $0 | | 03/05/2015 |
| 03/05/2015 | Allergan plc | AGN | Payment of Exercise | Ordinary Shares, par value $0.0001 | 269 | $295.70 | $79.5k | | 03/05/2015 |
| 07/01/2014 | Allergan plc | AGN | Grant | Stock Option (Right to Buy) | 22k | $224.00 | $4.9M | | 07/01/2014 |
| 07/01/2014 | Allergan plc | AGN | Grant | Performance-Based Restricted Stock Unit | 24.2k | $0.00 | $0 | | 07/01/2014 |
| 07/01/2014 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 7.8k | $0.00 | $0 | | 07/01/2014 |
| 05/09/2014 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 3k | $197.05 | $583.3k | | 05/09/2014 |
| 11/11/2013 | Allergan plc | AGN | Sale | Ordinary Shares | 30k | $159.30 | $4.8M | | 11/11/2013 |
| 10/01/2013 | Allergan plc | AGN | Grant | Ordinary Shares | 90k | $0.00 | $0 | | 10/01/2013 |
| 03/15/2013 | Actavis, Inc. | ACT | Payment of Exercise | Common Stock, par value $0.0033 | 933 | $91.59 | $85.5k | | 03/15/2013 |
| 03/12/2013 | Actavis, Inc. | ACT | Sale | Common Stock, par value $0.0033 | 8k | $89.00 | $712k | | 03/12/2013 |
| 03/12/2013 | Actavis, Inc. | ACT | Exercise | Non-Qualified Options to Purchase Common Stock | 1.6k | $38.92 | $62.3k | | 03/12/2013 |
| 03/12/2013 | Actavis, Inc. | ACT | Exercise | Non-Qualified Options to Purchase Common Stock | 6.4k | $38.92 | $249.1k | | 03/12/2013 |
| 05/25/2012 | Actavis, Inc. | ACT | Payment of Exercise | Common Stock, par value $0.0033 | 6.4k | $72.67 | $462.6k | | 05/25/2012 |
| 05/25/2012 | Actavis, Inc. | ACT | Exercise | Non-Qualified Options to Purchase Common Stock | 11.1k | $26.40 | $293.1k | | 05/25/2012 |
| 05/25/2012 | Actavis, Inc. | ACT | Exercise | Incentive Stock Options to Purchase Common Stock | 3.9k | $26.40 | $102.9k | | 05/25/2012 |
| 08/26/2011 | Actavis, Inc. | ACT | Exercise | Incentive Stock Options to Purchase Common Stock | 1 | $28.15 | $28.2 | | 08/26/2011 |
| 08/26/2011 | Actavis, Inc. | ACT | Exercise | Non-Qualified Options to Purchase Common Stock | 17.5k | $28.15 | $492.6k | | 08/26/2011 |
| 08/26/2011 | Actavis, Inc. | ACT | Sale | Common Stock, par value $0.0033 | 17.5k | $65.50 | $1.1M | | 08/26/2011 |
| 05/27/2011 | Actavis, Inc. | ACT | Sale | Common Stock, par value $0.0033 | 7k | $64.10 | $448.7k | | 05/27/2011 |
| 05/27/2011 | Actavis, Inc. | ACT | Exercise | Non-Qualified Options to Purchase Common Stock | 1.4k | $54.48 | $76.3k | | 05/27/2011 |
| 05/27/2011 | Actavis, Inc. | ACT | Exercise | Non-Qualified Options to Purchase Common Stock | 5.6k | $54.48 | $305.1k | | 05/27/2011 |
| 03/15/2011 | Actavis, Inc. | ACT | Grant | Common Stock, par value $0.0033 | 3.6k | $0.00 | $0 | | 03/11/2011 |
| 03/11/2011 | Actavis, Inc. | ACT | Payment of Exercise | Common Stock, par value $0.0033 | 1.4k | $56.89 | $78.2k | | 03/11/2011 |
| 03/05/2011 | Actavis, Inc. | ACT | Payment of Exercise | Common Stock, par value $0.0033 | 2.7k | $56.79 | $156k | | 03/05/2011 |
| 03/14/2010 | Actavis, Inc. | ACT | Payment of Exercise | Common Stock, par value $0.0033 | 2.8k | $41.37 | $113.8k | | 03/14/2010 |
| 02/24/2010 | Actavis, Inc. | ACT | Grant | Common Stock, par value $0.0033 | 16.5k | $0.00 | $0 | | 02/24/2010 |
|